Citizens Lifts Benitec Biopharma Inc. (BNTC) Price Target on Topline Results for Oculopharyngeal Muscular Dystrophy Treatment
Benitec Biopharma Inc. (NASDAQ:BNTC) is one of the best breakout stocks to invest in.
Benitec Biopharma Inc. (BNTC)
Market is closed
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Suvretta Capital Management Aaron Cowen | 11,548,351 | $154,516,936 | 2.83% | |
| 2. | Adage Capital Management Phill Gross And Robert Atchinson | 2,120,672 | $28,374,591 | 0.04% | |
| 3. | RA Capital Management Peter Kolchinsky | 1,850,000 | $24,753,000 | 0.22% | |
| 4. | Nantahala Capital Management Wilmot B. Harkey And Daniel Mack | 1,488,371 | $19,914,404 | +4% | 0.66% |
| 5. | Millennium Management Israel Englander | 921,299 | $12,326,981 | +42% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $13.44 | 11,587 | $155,729.28 | 1,848,156 | 2025-12-29 | Filing | |
| $13.44 | 65,800 | $884,352.00 | 9,700,195 | 2025-12-29 | Filing | |
| $13.10 | 2,516 | $32,959.60 | 1,836,569 | 2025-12-26 | Filing | |
| $13.10 | 14,320 | $187,592.00 | 9,634,395 | 2025-12-26 | Filing | |
| $12.85 | 7,400 | $95,090.00 | 1,834,053 | 2025-12-23 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 2,478,547 | $33,113,388 | 0.01% | |
| 2. | 2,412,888 | $32,284,447 | 0.01% | |
| 3. | 1,407,138 | $18,827,507 | 0% | |
| 4. | 1,005,557 | $13,454,353 | 0.19% | |
| 5. | 954,533 | $12,771,652 | 0% |
News See All
10 Best Breakout Stocks to Invest In
The US stock market is running high, hitting record highs, bolstered in part by continued optimism around artificial intelligence.
11 Best ASX Stocks To Buy Now
In this piece, we will take a look at the 11 best ASX stocks to buy now.